Alexa, What is Eliquis and Xarelto?

Not Applicable

Terminated

• Conditions: Patient Engagement; Patient Satisfaction
• Interventions: Other: Amazon Alexa based voice recording patient education

• Registration Number: NCT04790773
• Lead Sponsor: Cedars-Sinai Medical Center

Brief Summary

The purpose of this study is to evaluate the effectiveness of providing patient medication education about Eliquis and Xarelto through an Amazon Alexa based voice recording.

Detailed Description

Anticoagulants are considered high-risk medications due to the risk of major bleeding. The Federal Drug and Food Administration (FDA) MedWatch reporting system found that anticoagulants had the most adverse drug event (ADE) reports in 2011. Anticoagulants have also been reported as one of the leading drug classes contributing to emergency department visits3. Given the potential for serious adverse events, providing effective education to increase patient knowledge and awareness of those risks are essential. Incorporating technology into health care is becoming increasingly popular and has been shown to be effective for patient education. One reason is that technology can consistently provide complete patient education and is not subject to educator variability in providing this education.

Study Timeline

• Study First Submitted: 2021-03-08
• Study First Submitted QC: 2021-03-08
• Study First Posted: 2021-03-10
• Study Start: 2021-05-21
• Primary Completion: 2021-06-30
• Study Completion: 2021-10-31
• Status Verified: 2022-03
• Last Update Submitted: 2022-03-07
• Last Update Posted: 2022-03-21

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Not provided

Exclusion Criteria

• Patients will be excluded if they have documented altered mental status, do not speak English, or are being prescribed rivaroxaban or apixaban on discharge only.
• Nurses will be excluded if not providing direct patient care in select general medicine and orthopedic surgical units
• Nurses declining participation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Alexa Education	Amazon Alexa based voice recording patient education	Patient's will opt in to receive initial education via Alexa based voice recording on Xarelto and Eliquis.

Primary Outcome Measures

Name	Time	Method
% Change in pre- and post test scores	Within 72 hours of education	Effectiveness of Alexa based education by assessing understanding of Eliquis and Xarelto pre and post Alexa education

Secondary Outcome Measures

Name	Time	Method
7-day post-education retention rate	1 week post discharge	Assess education retention rate 7-days after initial Alexa based education performed
Patient satisfaction	72 hours	Patient satisfaction assessed by likert type scale questionnaire; 1. How satisfied are you with the anticoagulant education provided by Alexa? Responses: Very dissatisfied - Dissatisfied - Neutral - Satisfied - Very Satisfied; 2. How strongly would you recommend using Alexa anticoagulant education to your friends, family and/or other patients? Responses: Highly recommend - Recommend - Neutral - Do not recommend
Nursing satisfaction	72 hours	Nursing satisfaction assessed by likert type scale questionnaire; 1. How satisfied are you with the Alexa anticoagulation education process compared to standard of care? Responses: Very dissatisfied - Dissatisfied - Neutral - Satisfied - Very Satisfied; 2. Do you agree or disagree that Alexa helps with your day-to-day workload? Responses: Strongly Agree - Agree - Neutral - Disagree - Strongly disagree

Trial Locations

Locations (1)

Cedars Sinai Medical Center; 🇺🇸 Los Angeles, California, United States